HKSE:0241
Alibaba Health Information Technology Limited · HKSE · Healthcare · HKD · FY for 2026
Figures on this page computed 2026-11-08 13:34 UTC
Last close
n/aHKD
Market data
22.0xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2026
12.8%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
- Computed from the filing for 2026
5.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2026
- Computed from the filing for 2026
3.6%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2026
- Computed from the filing for 2026
0.003Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2026
- Computed from the filing for 2026
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth17.2%77 of 100, above its sector
- Returns on capital12.8%76 of 100, above its sector
- Margins24.0%49 of 100, above its sector
- Price22.0x41 of 100, above its sector
- Safety0.00388 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
All from 100
lens 2 of 9Sales
7,210Shares in issue
198- Profit, where the first year is 100: n/aNot enough filed years carry this line for it to be drawn. No line is drawn flat in its place.
Sales is at 7210, Shares in issue is at 198, against 100 in 2017.
Sales is at 7210, Shares in issue is at 198, against 100 in 2017.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2026
Sales, where the first year is 1007,210
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- CNY
Profit, where the first year is 100n/a
Not held.
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- CNY
Shares in issue, where the first year is 100198
- Source
- computed
- Statement
- income
- Fiscal year
- 2026
- Reported in
- CNY